28 unknown. 28 Phase 3, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 28 | Unknown 28 |
| Phase 2 | 9 | Unknown 9 |
Follow Mood Disorders: new trials by email Literature Review of Mood Disorders trials Research Report on Mood Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression INtegral Cognitive REMediation program, Psychoeducation for depression - Depression, Depressive Disorder | Phase 3 | Unknown | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 296 | 2023-09-13 | 2024-10-01 |
| Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities Vortioxetine, Venlafaxine - Major Depressive Disorder | Phase 3 | Unknown | Scotmann Pharmaceuticals | 500 | 2022-02-01 | 2021-11-18 |
| TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic Transcranial Direct Current Stimulation, Placebo-simulation of transcranial direct current stimulation, Fluoxetine Tablets - Major Depressive Disorder | Phase 2 / Phase 3 | Unknown | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | 172 | 2021-10-01 | 2021-06-04 |
| The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder FMT oral Capsules, Placebo Capsules - Depression, Treatment Resistant Depression | Phase 2 / Phase 3 | Unknown | University of Calgary | 80 | 2021-03-04 | 2023-11-28 |
| The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome Comorbidity Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175, placebo - Depressive Disorder, Depression | Phase 3 | Unknown | Medical University of Lodz | 200 | 2020-12-17 | 2021-02-16 |
| Comparison of Anyu Peibo With Placebo in Treatment of MDD in China Anyu Peibo, Placebo - Major Depressive Disorder | Phase 3 | Unknown | Shanghai Mental Health Center | 266 | 2020-01-23 | 2020-05-12 |
| NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation NRX-101, Lurasidone HCl - Bipolar Depression, Suicidal Ideation | Phase 3 | Unknown | NeuroRx, Inc. | 72 | 2019-12-01 | 2024-01-19 |
| A Study of Staccato Loxapine (ADASUVE®) for Inhalation Inhaled loxapine, Inhaled placebo - Psychomotor Agitation, Schizophrenia | Phase 3 | Unknown | Lee's Pharmaceutical Limited | 150 | 2019-12-01 | 2019-11-05 |
| add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients Memantine or placebo - Bipolar II Disorder | Phase 2 / Phase 3 | Unknown | National Cheng-Kung University Hospital | 120 | 2019-08-01 | 2021-03-09 |
| NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression Ketamine Hydrochloride, Placebo - Bipolar Depression, Suicidal Ideation | Phase 3 | Unknown | NeuroRx, Inc. | 150 | 2019-06-25 | 2024-01-19 |
| Evaluation of Schemes of Administration of Intravenous Ketamine in Depression Ketamine 50 MG/ML Injectable Solution, 0.5 mg/kg IV - Treatment Resistant Depression | Phase 3 | Unknown | National Institute of Neurology and Neurosurgery, Mexico | 30 | 2018-10-01 | 2019-09-10 |
| A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression Abilify 2, 5, 10, 15mg (Tablet), Placebo of Abilify 2, 5, 10, 15mg (Tablet) - Depression, Bipolar | Phase 3 | Unknown | Korea Otsuka Pharmaceutical Co., Ltd. | 390 | 2018-02-22 | 2024-08-19 |
| Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder Allogenic FMT, Autologous FMT - Bipolar Depression | Phase 2 / Phase 3 | Unknown | Valerie Taylor | 35 | 2018-01-01 | 2022-05-04 |
| Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder PH80, Placebo intranasal spray - Premenstrual Dysphoric Disorder | Phase 3 | Unknown | Pherin Pharmaceuticals, Inc. | 1400 | 2016-03-01 | 2015-12-03 |
| Transcranial Direct Current Stimulation as an Augmenting Intervention for Major Depression Transcranial Direct Current Stimulation - Major Depressive Disorder | Phase 2 / Phase 3 | Unknown | Douglas Mental Health University Institute | 30 | 2016-01-01 | 2016-01-20 |
| The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression Ketamine, Saline - Suicidal Ideation, Major Depressive Disorder | Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2014-01-01 | 2020-04-02 |
| A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder Sustained-Release Desvenlafaxine Hydrochloride, Sustained-Release Venlafaxine Hydrochloride - Major Depressive Disorder | Phase 2 / Phase 3 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 300 | 2013-10-01 | 2013-11-06 |
| An Open Prospective Trial of IV Ketamine in Suicidal Adolescents Ketamine - Major Depressive Disorder | Phase 2 / Phase 3 | Unknown | Nationwide Children's Hospital | 10 | 2013-06-01 | 2014-01-29 |
| Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder Dextromethorphan, Memantine, dextromethorphan+memantine - Bipolar Disorder II | Phase 3 | Unknown | National Cheng-Kung University Hospital | 300 | 2013-01-01 | 2017-07-11 |
| Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women Desvenlafaxine Succinate - Major Depressive Disorder, Menopausal Staging and Vasomotor Symptoms (for Females) | Phase 3 | Unknown | Hamilton Health Sciences Corporation | 90 | 2009-06-01 | 2012-02-08 |
Showing 20 of 28. Sign in to see all of them.
Depressive Disorder, Major (14) · Bipolar Disorder (10) · Depression (8) · Suicidal Ideation (3) · Depressive Disorder (2) · Depressive Disorder, Treatment-Resistant (2) · Anxiety Disorders (1) · COVID-19 (1) · Cognitive Dysfunction (1) · Depression, Postpartum (1) · Inflammation (1) · Mania (1) · Metabolic Syndrome (1) · Neurobehavioral Manifestations (1) · Non-alcoholic Fatty Liver Disease (1)
Mental Disorders (28) · Depressive Disorder (16) · Behavior (12) · Behavioral Symptoms (12) · Bipolar and Related Disorders (10) · Pathological Conditions, Signs and Symptoms (5) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Self-Injurious Behavior (3) · Signs and Symptoms (3) · Suicide (3) · Neurobehavioral Manifestations (2) · Pathologic Processes (2) · Aberrant Motor Behavior in Dementia (1)
Ketamine (4) · Memantine (2) · Transcranial Direct Current Stimulation (2) · Antidepressive Agents (1) · Desvenlafaxine Succinate (1) · Dextromethorphan (1) · Escitalopram (1) · Fecal Microbiota Transplantation (1) · Fluoxetine (1) · Lithium Carbonate (1) · Loxapine (1) · Lurasidone Hydrochloride (1) · Psychiatric Status Rating Scales (1) · Quetiapine Fumarate (1) · Risperidone (1)
Hospital de Clinicas de Porto Alegre (2) · National Cheng-Kung University Hospital (2) · NeuroRx, Inc. (2) · Centre hospitalier de Ville-Evrard, France (1) · Chinese University of Hong Kong (1) · Douglas Mental Health University Institute (1) · El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Hamilton Health Sciences Corporation (1) · JDS Pharmaceuticals (1) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Korea Otsuka Pharmaceutical Co., Ltd. (1) · Lee's Pharmaceutical Limited (1) · Medical University of Lodz (1) · National Institute of Neurology and Neurosurgery, Mexico (1)
United States (7) · Canada (5) · China (3) · Brazil (2) · Mexico (2) · Taiwan (2) · France (1) · Israel (1) · Poland (1) · South Korea (1) · Spain (1)
Martin Brecher, MD (2) · Valerie Taylor, MD, PhD (2) · Claudio N Soares, MD, PhD (1) · Dominic TS Lee, M.D. (1) · Ellen W Freeman, PhD (1) · Flavio Kapczinski, MD,PhD (1) · Gabor I Keitner, M.D. (1) · Huafang LI, MD. PhD. (1) · Huafang Li, Professor (1) · John C Perry, M.P.H., M.D. (1) · Jon F. Heiser, MD (1) · Marcelo T. Berlim, MD, MSc (1) · Maria J Portella, Dr (1) · Muhammad Umar (1)
PMID 23273725, PMID 10686270, PMID 10990547, PMID 11063978, PMID 11723286, PMID 12244081, PMID 12813115, PMID 12949224, PMID 14677403, PMID 15147306, PMID 15351385, PMID 15644873, PMID 15677610, PMID 15748841, PMID 15987799, PMID 16002441, PMID 16390886, PMID 16794566, PMID 16894061, PMID 17074942, PMID 17210143, PMID 17541113, PMID 17591596, PMID 18073775, PMID 18188442, PMID 18704022, PMID 18801471, PMID 19058788, PMID 19332318, PMID 19403329, PMID 19671217, PMID 19853048, PMID 20194822, PMID 20616670, PMID 20633386, PMID 20661246, PMID 20673547, PMID 20679587, PMID 20700385, PMID 20884642, PMID 21068312, PMID 21145043, PMID 21167786, PMID 21232924, PMID 21631313, PMID 21672551, PMID 21890211, PMID 22032743, PMID 22189047, PMID 22193671